vs
Side-by-side financial comparison of AvalonBay Communities (AVB) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
AvalonBay Communities is the larger business by last-quarter revenue ($767.9M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). AvalonBay Communities runs the higher net margin — 9040.6% vs 6.8%, a 9033.8% gap on every dollar of revenue. On growth, AvalonBay Communities posted the faster year-over-year revenue change (3.7% vs -1.7%). Over the past eight quarters, AvalonBay Communities's revenue compounded faster (3.8% CAGR vs -0.1%).
AvalonBay Communities, Inc. is a publicly traded real estate investment trust that invests in apartments.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
AVB vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $767.9M | $493.8M |
| Net Profit | $166.0M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 64.2% | 9.9% |
| Net Margin | 9040.6% | 6.8% |
| Revenue YoY | 3.7% | -1.7% |
| Net Profit YoY | -41.2% | 10.5% |
| EPS (diluted) | $1.18 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $767.9M | $493.8M | ||
| Q3 25 | $766.8M | $492.9M | ||
| Q2 25 | $760.2M | $468.8M | ||
| Q1 25 | $745.9M | $458.4M | ||
| Q4 24 | $740.5M | $502.4M | ||
| Q3 24 | $734.3M | $511.2M | ||
| Q2 24 | $726.0M | $504.3M | ||
| Q1 24 | $712.9M | $495.1M |
| Q4 25 | $166.0M | $33.7M | ||
| Q3 25 | $381.3M | $71.7M | ||
| Q2 25 | $268.7M | $39.3M | ||
| Q1 25 | $236.6M | $20.7M | ||
| Q4 24 | $282.1M | $30.5M | ||
| Q3 24 | $372.5M | $19.4M | ||
| Q2 24 | $253.9M | $-153.0M | ||
| Q1 24 | $173.4M | $4.0M |
| Q4 25 | 64.2% | 9.9% | ||
| Q3 25 | 65.7% | 13.8% | ||
| Q2 25 | 67.6% | 12.8% | ||
| Q1 25 | 68.5% | 7.0% | ||
| Q4 24 | 63.1% | 7.8% | ||
| Q3 24 | 65.4% | 6.6% | ||
| Q2 24 | 66.6% | -31.3% | ||
| Q1 24 | 67.2% | 3.2% |
| Q4 25 | 9040.6% | 6.8% | ||
| Q3 25 | 49.7% | 14.5% | ||
| Q2 25 | 35.3% | 8.4% | ||
| Q1 25 | 31.7% | 4.5% | ||
| Q4 24 | 38.1% | 6.1% | ||
| Q3 24 | 50.7% | 3.8% | ||
| Q2 24 | 35.0% | -30.3% | ||
| Q1 24 | 24.3% | 0.8% |
| Q4 25 | $1.18 | $0.40 | ||
| Q3 25 | $2.68 | $0.84 | ||
| Q2 25 | $1.88 | $0.46 | ||
| Q1 25 | $1.66 | $0.24 | ||
| Q4 24 | $1.99 | $0.37 | ||
| Q3 24 | $2.61 | $0.23 | ||
| Q2 24 | $1.78 | $-1.84 | ||
| Q1 24 | $1.22 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $187.2M | $375.2M |
| Total DebtLower is stronger | $9.3B | $570.5M |
| Stockholders' EquityBook value | $11.6B | $865.9M |
| Total Assets | $22.2B | $2.2B |
| Debt / EquityLower = less leverage | 0.80× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $187.2M | $375.2M | ||
| Q3 25 | $123.3M | $340.1M | ||
| Q2 25 | $102.8M | $224.7M | ||
| Q1 25 | $53.3M | $99.0M | ||
| Q4 24 | $108.6M | $229.9M | ||
| Q3 24 | $552.4M | $103.8M | ||
| Q2 24 | $545.8M | $19.4M | ||
| Q1 24 | $287.9M | $8.0M |
| Q4 25 | $9.3B | $570.5M | ||
| Q3 25 | $8.7B | $577.2M | ||
| Q2 25 | $8.7B | $583.9M | ||
| Q1 25 | $8.3B | $590.5M | ||
| Q4 24 | $8.1B | $597.1M | ||
| Q3 24 | $8.4B | — | ||
| Q2 24 | $8.4B | — | ||
| Q1 24 | $8.0B | — |
| Q4 25 | $11.6B | $865.9M | ||
| Q3 25 | $11.9B | $890.7M | ||
| Q2 25 | $11.9B | $833.8M | ||
| Q1 25 | $11.9B | $789.2M | ||
| Q4 24 | $11.9B | $764.9M | ||
| Q3 24 | $11.9B | $732.5M | ||
| Q2 24 | $11.7B | $706.5M | ||
| Q1 24 | $11.7B | $856.2M |
| Q4 25 | $22.2B | $2.2B | ||
| Q3 25 | $21.9B | $2.2B | ||
| Q2 25 | $21.8B | $2.1B | ||
| Q1 25 | $21.2B | $2.0B | ||
| Q4 24 | $21.0B | $2.2B | ||
| Q3 24 | $21.3B | $2.1B | ||
| Q2 24 | $21.0B | $2.0B | ||
| Q1 24 | $20.6B | $2.2B |
| Q4 25 | 0.80× | 0.66× | ||
| Q3 25 | 0.73× | 0.65× | ||
| Q2 25 | 0.72× | 0.70× | ||
| Q1 25 | 0.70× | 0.75× | ||
| Q4 24 | 0.68× | 0.78× | ||
| Q3 24 | 0.70× | — | ||
| Q2 24 | 0.71× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7B | $114.1M |
| Free Cash FlowOCF − Capex | $1.4B | — |
| FCF MarginFCF / Revenue | 183.5% | — |
| Capex IntensityCapex / Revenue | 34.1% | — |
| Cash ConversionOCF / Net Profit | 10.07× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $2.5B | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | $114.1M | ||
| Q3 25 | $477.0M | $137.3M | ||
| Q2 25 | $377.8M | $137.2M | ||
| Q1 25 | $415.9M | $-117.5M | ||
| Q4 24 | $1.6B | $133.0M | ||
| Q3 24 | $486.2M | $91.8M | ||
| Q2 24 | $380.0M | $107.0M | ||
| Q1 24 | $412.9M | $-125.2M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $402.2M | — | ||
| Q2 25 | $317.1M | — | ||
| Q1 25 | $367.5M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $434.2M | — | ||
| Q2 24 | $333.0M | — | ||
| Q1 24 | $375.4M | — |
| Q4 25 | 183.5% | — | ||
| Q3 25 | 52.5% | — | ||
| Q2 25 | 41.7% | — | ||
| Q1 25 | 49.3% | — | ||
| Q4 24 | 191.0% | — | ||
| Q3 24 | 59.1% | — | ||
| Q2 24 | 45.9% | — | ||
| Q1 24 | 52.7% | — |
| Q4 25 | 34.1% | — | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | 8.0% | — | ||
| Q1 25 | 6.5% | — | ||
| Q4 24 | 26.1% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 6.5% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | 10.07× | 3.39× | ||
| Q3 25 | 1.25× | 1.91× | ||
| Q2 25 | 1.41× | 3.49× | ||
| Q1 25 | 1.76× | -5.66× | ||
| Q4 24 | 5.70× | 4.36× | ||
| Q3 24 | 1.31× | 4.72× | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 2.38× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVB
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
